|Day's Range||7.11 - 7.54|
|52 Week Range||6.51 - 28.11|
|PE Ratio (TTM)||-1.64|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives GNC Holdings, Inc. a score of 6. Our analysis is based on comparing GNC Holdings, Inc. with the following peers – Vitamin Shoppe, Inc., Walgreens Boots Alliance Inc, Rite Aid Corporation, Nutrastar International, Inc., Natural Health Trends Corp., Fresh Harvest Products, Inc., Herbalife Ltd. and Inergetics, Inc. ... Read more (Read more...)
On Jun 20 2017, we issued an updated research report on Pittsburgh, PA-based GNC Holdings, Inc. (GNC).
The CEO of Cardax Inc. said the selection of the company's astaxanthin compound CDX-085 to take part in the National Institute on Aging's anti-aging interventions testing program will have positive implications for the Hawaii-based business. The program, among the top aging research programs in the U.S., is funded by the National Institutes of Health and only selects 4-5 compounds every year through extensive screening for their potential impact on lifespan extension and their ability to delay disease and dysfunction in mice at different ages. "The NIH is about a $38 billion annual budget and their science is very serious and credible and the fact that they would choose our compound I think speaks to the credibility of our whole program" Cardax President and CEO David Watumull told Pacific Business News.